U.S., Aug. 13 -- ClinicalTrials.gov registry received information related to the study (NCT07117136) titled 'Blinatumomab Consolidation in Real World' on Aug. 05.

Brief Summary: This will be a multi-center registry for patients with B-ALL. Patient data will be collected both retrospectively and prospectively. The data forms and surveys will be built and managed through REDCap, a secure web application managed by the Clinical & Translational Science Institute.

Study Start Date: Sept. 01

Study Type: OBSERVATIONAL

Condition: B-Cell Acute Lymphoblastic Leukaemia

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Medical College of Wisconsin

Information provided by (Responsible Party): Ehab L Atallah, Medical College of Wisconsin

Published...